• Explore /
  • Poster
  • / Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors.

Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors.

Abstract Poster

Authors

null

Amin Nassar

Yale Cancer Center, New Haven, CT

Amin Nassar , Sarah Abou Alaiwi , Talal El Zarif , Ryan Austin Denu , Salim S. Hayek , Rachel S Goodman , Rachel Woodford , Tomas G. Neilan , Tarek Haykal , Yuji Kojima , Alexandra Trevino , Gavin Hui , Ankita Tandon , Edward El-Am , Arjun Mittra , Javier Baena , Arrush Choudhary , Shirly Grynberg , Toni K. Choueiri , Abdul Rafeh Naqash

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Other IO-Related Topics

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2653)

DOI

10.1200/JCO.2023.41.16_suppl.2653

Abstract #

2653

Poster Bd #

495

Abstract Disclosures

Similar Posters

First Author: Patrick Walsh McGarrah

First Author: Wint Yan Aung

First Author: Tämer El Saadany

First Author: Daniel Olson